59 related articles for article (PubMed ID: 19688061)
1. Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.
Choi JH; Oh SY; Kwon HC; Kim JH; Lee JH; Lee S; Lee DM; Kim SH; Rho MH; Kim YH; Rho MS; Kim HJ
Cancer Res Treat; 2008 Mar; 40(1):22-6. PubMed ID: 19688061
[TBL] [Abstract][Full Text] [Related]
2. Prolonged progression-free survival achieved by gemcitabine, cisplatin, and albumin-bound paclitaxel for the treatment of advanced biliary tract cancers.
Choi JH; Park H; Park JK; Lee JK; Lee KT; Lee KH
Ther Adv Med Oncol; 2024; 16():17588359231225045. PubMed ID: 38249335
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer.
Ai D; Guan Y; Liu XJ; Zhang CF; Wang P; Liang HL; Guo QS
Onco Targets Ther; 2016; 9():5693-5698. PubMed ID: 27695347
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.
Lee J; Hong TH; Lee IS; You YK; Lee MA
Cancer Res Treat; 2015 Apr; 47(2):259-65. PubMed ID: 25648099
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.
Wu Z; Gabrielson A; Hwang JJ; Pishvaian MJ; Weiner LM; Zhuang T; Ley L; Marshall JL; He AR
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1309-14. PubMed ID: 26507197
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
Li J; Merl M; Lee MX; Kaley K; Saif MW
Expert Opin Drug Saf; 2010 Mar; 9(2):207-13. PubMed ID: 20095915
[TBL] [Abstract][Full Text] [Related]
7. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
Zhang L; Li N; Xu F; Zhang Y
Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancer.
Kim JH; Oh SY; Kwon HC; Lee S; Kim SH; Kim DC; Lee JH; Lee HS; Cho SH; Kim HJ
Cancer Res Treat; 2008 Sep; 40(3):101-5. PubMed ID: 19688114
[TBL] [Abstract][Full Text] [Related]
9. [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].
Sun Q; Hua J; Hang X; Mao Y; Wang Q
Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):451-3. PubMed ID: 21205532
[TBL] [Abstract][Full Text] [Related]
10. Combination of gemcitabine and cisplatin as first-line therapy in advanced non-small-cell lung cancer.
Lee NS; Byun JH; Bae SB; Kim CK; Lee KT; Park SK; Won JH; Hong DS; Park HS
Cancer Res Treat; 2004 Jun; 36(3):173-7. PubMed ID: 20396540
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].
Zhao Y; Chen Y; Ji H; Chu T; Han B; Liao M
Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):449-51. PubMed ID: 21244803
[TBL] [Abstract][Full Text] [Related]
12. Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer.
Sohn BS; Yuh YJ; Song HS; Kim BS; Lee KH; Jang JS; Kim SR
Oncol Lett; 2015 Aug; 10(2):1204-1210. PubMed ID: 26622653
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined gemcitabine/cisplatin chemotherapy for locally advanced or metastatic urothelial cancer.
Bae KS; Ahn KI; Jeon SH; Huh JS; Chang SG
Cancer Res Treat; 2006 Apr; 38(2):78-83. PubMed ID: 19771264
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute.
Yu WX; Tang LN; Lin F; Yao Y; Shen Z
Oncol Lett; 2014 Nov; 8(5):2243-2248. PubMed ID: 25289103
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience.
Pande SB; Doval DC; Pavithran K; Sharma JB; Shirali R; Jena A
Indian J Med Paediatr Oncol; 2012 Jan; 33(1):42-7. PubMed ID: 22754208
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis.
Rizzo M; Chiellino S; Gernone A; Porta C
Front Oncol; 2022; 12():939953. PubMed ID: 36330500
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum.
Chen C; Zhang X; Zhou Y; Fu S; Lin Z; Hong S; Zhang L
Cancer Manag Res; 2020; 12():10353-10360. PubMed ID: 33116890
[TBL] [Abstract][Full Text] [Related]
18. Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5-Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis and Systematic Review.
Yan L; Zheng H; Ren B; Zhang H; Gou H; Dai L
J Oncol; 2022; 2022():7233559. PubMed ID: 35880116
[TBL] [Abstract][Full Text] [Related]
19. Long-time survival of a patient with metastatic pancreatic cancer: a case report.
Soldic Z; Zitnjak D; Bolanca A; Kusic Z
Case Rep Oncol; 2011 May; 4(2):367-70. PubMed ID: 21941484
[TBL] [Abstract][Full Text] [Related]
20. New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.
Buchholz M; Strotmann J; Majchrzak-Stiller B; Hahn S; Peters I; Horn J; Müller T; Höhn P; Uhl W; Braumann C
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
